Raj Narlawar

Raj Narlawar is an accomplished medicinal chemist with extensive experience in the pharmaceutical industry. Currently serving as Associate Director at Acerta Pharma B.V. since September 2023, Raj previously held roles at The Janssen Pharmaceutical Companies of Johnson & Johnson, including Senior Scientist and Visiting Scientist, where contributions were made to collaborative research on Alzheimer's disease. Prior to this, Raj was a Senior Staff Scientist at VIB & Janssen Research and Development, focusing on innovative research for therapeutically relevant compounds. Additionally, Raj's academic background includes postdoctoral positions at The University of Sydney and Leiden University, complemented by a PhD in Medicinal Chemistry from Technische Universität Darmstadt. Raj's early career includes work as a Senior Medicinal Chemist at Dr. Reddy's Laboratories, among other roles in research.